发明名称 |
Benzonatate modified release solid tablets and capsules |
摘要 |
A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay. |
申请公布号 |
US9408823(B2) |
申请公布日期 |
2016.08.09 |
申请号 |
US201514863784 |
申请日期 |
2015.09.24 |
申请人 |
Tris Pharma, Inc. |
发明人 |
Nelson Andrea;Chen Quin-Zene;Mehta Harsh;Tu Yu-Hsing |
分类号 |
A61K9/22;A61K31/245;A61K31/09;A61K9/24;A61K9/28;A61K45/06;A61K9/00;A61K9/20;A61K9/50 |
主分类号 |
A61K9/22 |
代理机构 |
Howson and Howson LLP |
代理人 |
Howson and Howson LLP ;Berg, Esq. Egon;Kodroff Cathy A. |
主权项 |
1. A modified release benzonatate solid oral composition comprising (a) a homogenous solid dispersion comprising (i) benzonatate adsorbed onto one or more of a silica, silicon dioxide or silicate to form a benzonatate adsorbate and (ii) at least one pharmaceutically acceptable modified release pH-independent, hydrophilic or hydrophobic matrix-forming substance in an amount effective to provide a modified release profile to the benzonatate, and (b) a coating over said homogenous solid dispersion,
wherein there is substantially no benzonatate release from the composition in the buccal cavity, and wherein the composition provides a pharmacokinetic profile for benzonatate, based on an equivalent of about a 300 mg dose of benzonatate administered at 12 hour intervals in a 24 hour period, of one or more of: a geometric mean area under the curve (AUC)inf of about 110 ng-h/mL to about 170 ng-h/mL, a geometric mean maximum plasma concentration (Cmax) of about 28 ng/mL to about 34 ng/mL and/or a Tmax of about 12 hours to 20 hours. |
地址 |
Monmouth Junction NJ US |